• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷脂酰肌醇3激酶通过D816V c-Kit突变体促进造血细胞的转化。

Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant.

作者信息

Chian R, Young S, Danilkovitch-Miagkova A, Rönnstrand L, Leonard E, Ferrao P, Ashman L, Linnekin D

机构信息

Basic Research Laboratory and the Laboratory of Immunobiology, Division of Basic Sciences, National Cancer Institute-Frederick, MD 21702, USA.

出版信息

Blood. 2001 Sep 1;98(5):1365-73. doi: 10.1182/blood.v98.5.1365.

DOI:10.1182/blood.v98.5.1365
PMID:11520784
Abstract

Stem cell factor (SCF) binds the receptor tyrosine kinase c-Kit and is critical for normal hematopoiesis. Substitution of valine for aspartic acid 816 (D816V) constitutively actives human c-Kit, and this mutation is found in patients with mastocytosis, leukemia, and germ cell tumors. Immortalized murine progenitor cells (MIHCs) transduced with wild-type c-Kit proliferate in response to SCF, whereas cells expressing D816V c-Kit (MIHC-D816V) are factor-independent and tumorigenic. However, the mechanisms mediating transformation by D816V c-Kit are unknown. The objective of this study was to identify signaling components that contribute to D816V c-Kit-mediated transformation. SCF stimulates association of p85PI3K with phosphorylated tyrosine 721 of wild-type c-Kit. Phosphatidylinositol 3 kinase (PI3K) subsequently contributes to the activation of Akt and Jnks. In contrast, these studies demonstrated that the D816V c-Kit mutant was constitutively associated with phosphorylated p85PI3K, and, downstream of PI3K, Jnk 1 and Jnk 2 were activated but Akt was not. Interestingly, Erks 1 and 2 were not constitutively activated by D816V c-Kit. Thus, D816V c-Kit maintains the activity of PI3K but not of all signaling pathways activated by wild-type c-Kit. Further, all pathways downstream of PI3K are not constitutively active in MIHC-D816V cells. Studies with a PI3K inhibitor and D816V/Y721F c-Kit, a mutant incapable of recruiting PI3K, indicate that constitutive activation of PI3K through direct recruitment by D816V c-Kit plays a role in factor-independent growth of MIHC and is critical for tumorigenicity.

摘要

干细胞因子(SCF)与受体酪氨酸激酶c-Kit结合,对正常造血至关重要。用缬氨酸替代天冬氨酸816(D816V)可组成性激活人c-Kit,且该突变见于肥大细胞增多症、白血病和生殖细胞肿瘤患者。用野生型c-Kit转导的永生化小鼠祖细胞(MIHCs)对SCF有反应而增殖,而表达D816V c-Kit的细胞(MIHC-D816V)不依赖因子且具有致瘤性。然而,D816V c-Kit介导转化的机制尚不清楚。本研究的目的是确定促成D816V c-Kit介导转化的信号成分。SCF刺激p85PI3K与野生型c-Kit磷酸化酪氨酸721的结合。磷脂酰肌醇3激酶(PI3K)随后促成Akt和Jnks的激活。相比之下,这些研究表明D816V c-Kit突变体与磷酸化p85PI3K组成性结合,并且在PI3K下游,Jnk 1和Jnk 2被激活但Akt未被激活。有趣的是,Erks 1和2未被D816V c-Kit组成性激活。因此,D816V c-Kit维持PI3K的活性,但不维持野生型c-Kit激活的所有信号通路的活性。此外,PI3K下游的所有通路在MIHC-D816V细胞中并非组成性激活。用PI3K抑制剂和D816V/Y721F c-Kit(一种无法募集PI3K的突变体)进行的研究表明,D816V c-Kit通过直接募集对PI3K的组成性激活在MIHC的不依赖因子生长中起作用,并且对致瘤性至关重要。

相似文献

1
Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant.磷脂酰肌醇3激酶通过D816V c-Kit突变体促进造血细胞的转化。
Blood. 2001 Sep 1;98(5):1365-73. doi: 10.1182/blood.v98.5.1365.
2
Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.血小板因子4通过细胞外信号调节激酶途径而非磷脂酰肌醇3激酶途径抑制成纤维细胞生长因子2诱导的内皮细胞增殖。
Blood. 2002 Nov 1;100(9):3087-94. doi: 10.1182/blood.V100.9.3087.
3
PI3 kinase is indispensable for oncogenic transformation by the V560D mutant of c-Kit in a kinase-independent manner.PI3激酶对于c-Kit的V560D突变体以非激酶依赖方式进行致癌转化是不可或缺的。
Cell Mol Life Sci. 2015 Nov;72(22):4399-407. doi: 10.1007/s00018-015-1944-9. Epub 2015 Jun 4.
4
Activation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor/stem cell lines.在造血祖细胞/干细胞系中,c-Kit对丝裂原活化蛋白激酶(MAP)激酶途径的激活依赖于磷脂酰肌醇-3激酶(PI-3激酶)。
Blood. 2004 Jul 1;104(1):51-7. doi: 10.1182/blood-2003-07-2554. Epub 2004 Mar 2.
5
Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway.与间变性大细胞淋巴瘤相关的核磷蛋白-间变性淋巴瘤激酶激活磷脂酰肌醇3-激酶/蛋白激酶B抗凋亡信号通路。
Blood. 2000 Dec 15;96(13):4319-27.
6
Downstream effectors of oncogenic ras in multiple myeloma cells.多发性骨髓瘤细胞中致癌性Ras的下游效应分子。
Blood. 2003 Apr 15;101(8):3126-35. doi: 10.1182/blood-2002-08-2640. Epub 2002 Dec 19.
7
The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit.c-Kit/D816V突变消除了c-Kit两种同工型在信号转导和生物学反应上的差异。
Cell Signal. 2009 Mar;21(3):413-8. doi: 10.1016/j.cellsig.2008.11.008. Epub 2008 Nov 17.
8
Role for the adaptor protein Grb10 in the activation of Akt.衔接蛋白Grb10在Akt激活中的作用。
Mol Cell Biol. 2002 Feb;22(4):979-91. doi: 10.1128/MCB.22.4.979-991.2002.
9
Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.磷脂酰肌醇3'-激酶是表达kit催化结构域突变体的肥大细胞生长所必需的。
Cancer Res. 2003 Aug 1;63(15):4412-9.
10
Signal transducer and activator of transcription 3 activation is required for Asp(816) mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells.信号转导及转录激活因子3的激活是天冬氨酸(816)突变型c-Kit介导的人白血病细胞不依赖细胞因子存活和增殖所必需的。
Blood. 2001 Jun 1;97(11):3559-67. doi: 10.1182/blood.v97.11.3559.

引用本文的文献

1
Fedratinib and gandotinib induce apoptosis and enhance the efficacy of tyrosine kinase inhibitors in human mast cells.非达替尼和甘多替尼可诱导人肥大细胞凋亡并增强酪氨酸激酶抑制剂的疗效。
Am J Cancer Res. 2025 Jan 15;15(1):84-98. doi: 10.62347/TYTU4465. eCollection 2025.
2
Detection of Mutations in Systemic Mastocytosis: How, When, and Why.系统性肥大细胞增多症的突变检测:方法、时机和原因。
Int J Mol Sci. 2024 Oct 10;25(20):10885. doi: 10.3390/ijms252010885.
3
The roles of phospholipase C-β related signals in the proliferation, metastasis and angiogenesis of malignant tumors, and the corresponding protective measures.
磷脂酶C-β相关信号在恶性肿瘤增殖、转移及血管生成中的作用及相应的防护措施。
Front Oncol. 2023 Jul 28;13:1231875. doi: 10.3389/fonc.2023.1231875. eCollection 2023.
4
Role and significance of c-KIT receptor tyrosine kinase in cancer: A review.c-KIT 受体酪氨酸激酶在癌症中的作用和意义:综述。
Bosn J Basic Med Sci. 2022 Sep 16;22(5):683-698. doi: 10.17305/bjbms.2021.7399.
5
Recent Advances in the Molecular Biology of Systemic Mastocytosis: Implications for Diagnosis, Prognosis, and Therapy.系统性肥大细胞增多症的分子生物学新进展:对诊断、预后和治疗的影响。
Int J Mol Sci. 2020 Jun 2;21(11):3987. doi: 10.3390/ijms21113987.
6
Loss of PI3 kinase association improves the sensitivity of secondary mutation of KIT to Imatinib.PI3激酶结合的丧失提高了KIT二次突变对伊马替尼的敏感性。
Cell Biosci. 2020 Feb 12;10:16. doi: 10.1186/s13578-020-0377-9. eCollection 2020.
7
Inhibition of N822K T>A mutation-induced constitutive c-KIT activation in AML cells triggers apoptotic and autophagic pathways leading to death.抑制 AML 细胞中 N822K T>A 突变诱导的组成性 c-KIT 激活会触发凋亡和自噬途径,导致细胞死亡。
Int J Med Sci. 2019 May 21;16(5):757-765. doi: 10.7150/ijms.33532. eCollection 2019.
8
Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis.胃肠道间质瘤(GIST)和肥大细胞增多症中KIT的种系突变。
Cell Biosci. 2016 Oct 18;6:55. doi: 10.1186/s13578-016-0120-8. eCollection 2016.
9
Control of Oocyte Reawakening by Kit.Kit对卵母细胞重新激活的调控
PLoS Genet. 2016 Aug 8;12(8):e1006215. doi: 10.1371/journal.pgen.1006215. eCollection 2016 Aug.
10
Oncogenic KIT mutations in different exons lead to specific changes in melanocyte phospho-proteome.不同外显子中的致癌性KIT突变导致黑素细胞磷酸化蛋白质组的特定变化。
J Proteomics. 2016 Jul 20;144:140-7. doi: 10.1016/j.jprot.2016.05.019. Epub 2016 May 20.